| Literature DB >> 321265 |
A Corbin, C W Beattie, R Rees, J Yardley, T J Foell, S Y Chai, H McGregor, V Garsky, D Sarantakis, W A McKinley.
Abstract
Various analogs of synthetic hypothalamic luteinizing hormone-releasing hormone (LH-RH) were evaluated for agonistic (ovulation-inducing), postcoital contraceptive, and direct uterotrophic activities. All analogs showing agonistic activity also possessed the ability to terminate pregnancy, as did LH-RH; there appeared to be a direct relationship between agonistic and postcoital potency and activity. The highly potent and active LH-RH agonist, D-[Ala]6-des-[Gly]10-pro9-ethylamide-LH-RH, proved to be the most potent and active postcoital preimplantational and postimplantational antifertility agent. In contrast to LH-RH, none of the analogs tested in the hypophysectomized animal produced a uterotrophic effect, revealing a selective extrapituitary effect of the parent hormone. The collective data demonstrate that peptides derived from LH-RH and bearing agonistic properties can terminate pregnancy postcoitally, via disruption of the pituitary-ovarian reproductive complex. Possible mechanisms are discussed, and the use of members of this neurohormonal class as potential profertility agents should be weighed with caution.Entities:
Mesh:
Substances:
Year: 1977 PMID: 321265 DOI: 10.1016/s0015-0282(16)42500-8
Source DB: PubMed Journal: Fertil Steril ISSN: 0015-0282 Impact factor: 7.329